ClinicalTrials.Veeva

Menu

Seroprevalence of Covid-19 in the Staff of the University Hospitals of Strasbourg (SeroPrevHUS)

U

University Hospital, Strasbourg, France

Status

Completed

Conditions

COVID-19

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The Grand Est region is one of the most affected regions in France during the first wave of the COVID-19 epidemic. A significant increase in the number of patients hospitalized for SARS-CoV 2 infection at the University Hospitals of Strasbourg (HUS) led to a sudden saturation of their capacities. Hospital workers appear to be a population at particular risk for this new infectious agent. The percentage of hospital workers who have been in contact with the virus or have contracted COVID-19 is unknown.

The objective of this work is to determine the prevalence of SARS-CoV-2 positive serologies among hospital staff screened from June 22, 2020 to November 1, 2020 following a screening campaign offering serological testing to all volunteer HUS professionals.

Enrollment

5,694 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult subject (≥ 18 years of age)
  • Hospital staff practicing at HUS who performed SARS-CoV 2 serology in the period from 06/22/2020 to 11/1/2020

Exclusion criteria

  • Subject not meeting inclusion criteria

Trial contacts and locations

1

Loading...

Central trial contact

Samira FAFI-KREMER, PharmD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems